FDA Grants Marketing Authorization for System that Monitors Opioid Use Health Risks
The FDA granted marketing authorization for a device that recognizes when someone experiences opioid-induced respiratory depression.
The FDA granted marketing authorization for a device that recognizes when someone experiences opioid-induced respiratory depression.
Asensus Surgical received FDA 510(k) clearance for an expanded indication to treat pediatric patients with the Senhance Surgical System.
Leaders of medical device field-service teams are paying attention to ways they can help professionals build skills for consistent performance. Here is how.
The FDA granted marketing authorization for a device that recognizes when someone experiences opioid-induced respiratory depression.
MediPines announced that its FDA-cleared, non-invasive pulmonary gas exchange analyzer, the MediPines AGM100, is now available in Canada.
GE HealthCare is recalling the Nuclear Medicine 600 and 800 Series systems after identifying an issue with two of its mechanisms.
Getinge subsidiary Datascope is recalling two types of Intra-Aortic Balloon Pumps due to the possibility of unexpected device shutdown.
A new industry blueprint was published to help healthcare IT leaders better understand zero-trust principles and examine vendor architectures.
ECRI released an enhanced technology solution designed to improve new healthcare product and standardization decisions.
Konica Minolta Healthcare Americas Inc. announces that it will introduce its compact, point-of-care ultrasound system, SonImage MX1 Platinum, at the 2022 Annual Meeting of the Radiological Society of North America, which takes place from November 27-December 1 in Chicago.
Parachute Health's durable medical equipment ePrescribing Platform has earned Certified status for information security by HITRUST.
Philips Respironics recalled certain reworked ventilators for issues related to foam adhesion failure and foam debris.
Medisafe, a digital therapeutics company specializing in medication engagement, has unveiled its new Software as a Medical Device technology.
Spacelabs Healthcare agreed to pay $2.5 million to resolve allegations that it overcharged the U.S. for patient monitoring equipment.